Tech Company Acquirers
Onyx Pharmaceuticals
Proteolix was purchased by Onyx Pharmaceuticals, a leading biopharmaceutical growth company, based in South San Francisco.
Company Overview
Company Name
Onyx Pharmaceuticals
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Acquisitions
Contact Information
Mailing Address
249 E. Grand Avenue
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. Our lead product is Nexavar (sorafenib), a novel, oral multiple kinase inhibitor that targets proteins involved in both tumor cell proliferation and angiogenesis.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/12/2009
Acquisitions By Onyx Pharmaceuticals
Date
Company
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anthony Coles
Chief Financial Officer
Matthew Fust
VP - Bus. Development
Juergen Lasowski
VP - General Counsel
Suzanne Shema
VP - Human Resources
Kaye Foster-Chee
VP - R & D
Pablo Cagnoni
Browse more tech company acquirers:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs